U.S. Markets open in 2 hrs 30 mins

Before You Buy Standrew SA’s (WSE:STD), Consider This

Lawrence Carr

If you are looking to invest in Standrew SA’s (WSE:STD), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your portfolio. Every stock in the market is exposed to market risk, which arises from macroeconomic factors such as economic growth and geo-political tussles just to name a few. This is measured by its beta. Not all stocks are expose to the same level of market risk, and the broad market index represents a beta value of one. Any stock with a beta of greater than one is considered more volatile than the market, and those with a beta less than one is generally less volatile.

Check out our latest analysis for Standrew

An interpretation of STD’s beta

Standrew’s five-year beta of 1.64 means that the company’s value is expected to be more volatile than average. Based on this beta value, STD can help magnify your portfolio return, especially if it is predominantly made up of low-beta stocks. If the market is going up, a higher exposure to the upside from a high-beta stock can push up your portfolio return.

WSE:STD Income Statement Export August 12th 18

Does STD’s size and industry impact the expected beta?

STD, with its market capitalisation of zł7.70m, is a small-cap stock, which generally have higher beta than similar companies of larger size. Furthermore, the company operates in the forestry industry, which has been found to have high sensitivity to market-wide shocks. So, investors should expect a larger beta for smaller companies operating in a cyclical industry in contrast with lower beta for larger firms in a more defensive industry. This supports our interpretation of STD’s beta value discussed above. Next, we will examine the fundamental factors which can cause cyclicality in the stock.

Can STD’s asset-composition point to a higher beta?

An asset-heavy company tends to have a higher beta because the risk associated with running fixed assets during a downturn is highly expensive. I test STD’s ratio of fixed assets to total assets in order to determine how high the risk is associated with this type of constraint. STD’s fixed assets to total assets ratio of higher than 30% shows that the company uses up a big chunk of its capital on assets that are hard to scale up or down in short notice. Thus, we can expect STD to be more volatile in the face of market movements, relative to its peers of similar size but with a lower proportion of fixed assets on their books. Similarly, STD’s beta value conveys the same message.

What this means for you:

You could benefit from higher returns from STD during times of economic growth. Its higher fixed cost isn’t a major concern given margins are covered with high consumer demand. Though, in times of a downturn, it may be safe to look at a more defensive stock which can cushion the impact of lower demand. What I have not mentioned in my article here are important company-specific fundamentals such as Standrew’s financial health and performance track record. I urge you to complete your research by taking a look at the following:

  1. Future Outlook: What are well-informed industry analysts predicting for STD’s future growth? Take a look at our free research report of analyst consensus for STD’s outlook.
  2. Past Track Record: Has STD been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of STD’s historicals for more clarity.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.